References
- Vokes EE, Vilayakumar S, Bitran ID et al. Role of systemic therapy in advanced non-small cell lung cancer. Am J Med 1990; 89: 777–86.
- Jonhson DH. Chemotherapy for unresectable non-small cell lung cancer. Semin Oncol 1990; 17 (Suppl 7): 20–29.
- Joss RA, Cavalli F, Goldhirrsch A et al. New agents in non-small cell lung cancer. Cancer Treat Rev 1984; 11: 205–36.
- Kris MG, Gralla RJ, Kalmann LA et al. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 1985; 69: 387–95.
- Ruckdeschel JC, Finkelstein DH, Mason BA, Creech RH. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575 generation V – a randomized comparison of four cisplatin containing regimens. J Clin On-col 1985; 3: 72–9.
- Scagliotti GV, Lodico D, Gozellino F et al. Unresectable non small cell lung cancer chemotherapy with high dose cisplatin and etoposide. Oncology 1985; 42: 224–8.
- Schulman P, Budman DR, Weiselberg L et al. Phase II trial of mitomycin, vinblastine and cisplatin (MVP) in non-small cell bronchogenic carcinoma. Cancer Treat Rep 1983; 67: 943–5.
- Alberts DS. Clinical pharmacology of carboplatin. Sem-in Oncol 1990; 17 (Suppl 7): 6–8.
- Bun PA. Review of therapeutic trials of carboplatin in lung cancer. Semin Oncol 1989; 16 (Suppl 5): 27–33.
- Lelieveld P, Van Der Vijgh WJF, Weldhui en RW et al. Preclinical studies on toxicity, antitumor activity and pharma cokinetics of cisplatin and three recently developed derivatives. Eur J Cancer Clin Oncol 1984; 20: 1087–1105.
- Curt GA, Gryciel JJ, Corden BJ et al. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxyl-atoplatinum (NSC 241240). Cancer Res 1983; 43: 4470–3.
- Bonomi PD, Finkelstein DM, Ruckdeschel JC et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 1989; 7: 1602–13.
- Belani CP, Abrams JS, Egorin MJ et al. Carboplatin and etoposide in advanced or recurrent non-small cell lung carcinoma, (abstr.). Proc Am Soc Clin Oncol 1989; 8: 242.
- Klastersky J, Sculier JP, Lacroix H et al. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer. J Clin Oncol 1989; 8: 1556–62.
- Finkelstein DM, Ettinger DS, Ruckdeschel JC. Long term survivors in metastatic non-small cell lung cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 1986; 4: 702–9.
- Ruckdeschel JC, Finkelstein DM, Ettinger DS et al. A randomized trial of the four most active regimens for metas-tatic non-small cell lung cancer. J Clin Oncol 1986; 4: 14–22.